Boyin Bio is an innovative biomaterial research and development and application company, driven by synthetic biology and machine learning (BT-IT) dual-core technology, committed to the development of bio-based materials and related products, providing customers with safe and efficient green solutions. Today, Baiyin Biology announced that it has completed the Pre-A round of financing of more than 100 million yuan. Woyong Fund, Yunqi Capital, Fuhua Capital jointly led the investment, Co-Stone Capital and Yayi Capital followed up the investment, and Light Source Capital acted as the exclusive financial advisor. After the completion of this round of financing, Baiyin will further strengthen the upgrade of the R&D platform and the expansion of production capacity.
This article is transferred from: https://www.itjuzi.com/investevent/13770945
This site is only for collection, and the copyright belongs to the original author.